Skip to main content
SpringerLink
Log in

Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population

Journal of Diabetes & Metabolic Disorders volume 17, pages 37–43 (2018)Cite this article

Abstract

Background

It is unknown whether inflammation plays a role in metabolic dysfunction on ketosis-prone diabetes (KPD). We aimed to assess the inflammatory profile in sub-Saharan African patients with KPD during the acute ketotic phase as well as during non-ketotic hyperglycemic crises.

Methods

We studied 72 patients with non-autoimmune diabetes: 23 with type 2 diabetes mellitus (T2D), and 49 with KPD, all admitted in hyperglycemic crisis (plasma glucose ≥250 mg/dl). The T2D and KPD groups were matched by sex, age, and Body Mass Index. KPD was sub-classified into new-onset ketotic phase (n = 34) or non-ketotic phase (n = 15). We measured TNF-α, MCP-1, MIP1-α, IL-8, MIP1-β, and VEGF in the serum of all participants.

Results

TNF-α and IL-8 were higher in participants with KPD compared to those with T2D (p = 0.02 TNF-α; p = 0.03 IL-8). TNF-α and IL-8 were also higher in the ketotic phase KPD group compared to the T2D group (p = 0.03 TNF-α; p < 0.001 IL-8) while MIP1-α was lower in people with ketotic phase KPD compared to their T2D counterparts (p = 0.03). MIP1-α was lower in the ketotic phase KPD group compared to the non-ketotic phase KPD group (p = 0.04). MCP-1 was lower in non-ketotic phase KPD compared to T2D (p = 0.04), and IL-8 was higher in non-ketotic phase KPD compared to T2D (p = 0.02).

Conclusions

Participants with KPD had elevated pro-inflammatory cytokines compared to their T2D counterparts. Ketotic phase KPD is associated with a different pro-inflammatory profile compared to non-ketotic phase KPD, and the inflammatory profile appears to be comparable between non-ketotic phase KPD and T2D patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. Leahy JL, Hirsch IB, Peterson KA, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95(9):4206–16.

    Article  PubMed  CAS  Google Scholar 

  2. Dobrian AD, Galkina EV, Ma Q, Hatcher M, Aye SM, Butcher MJ, et al. STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation. Diabetes. 2013;62(12):4109–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Kiely A, McClenaghan NH, Flatt PR, Newsholme P. Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic beta-cell line. J Endocrinol. 2007;195(1):113–23.

    Article  PubMed  CAS  Google Scholar 

  4. Souza KL, Gurgul-Convey E, Elsner M, Lenzen S. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells. J Endocrinol. 2008;197(1):139–50.

    Article  PubMed  CAS  Google Scholar 

  5. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–44.

    Article  PubMed  CAS  Google Scholar 

  6. Menart-Houtermans B, Rutter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German diabetes study (GDS). Diabetes Care. 2014;37(8):2326–33.

    Article  PubMed  CAS  Google Scholar 

  7. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013;110(13):5133–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Igoillo-Esteve M, Marselli L, Cunha DA, Ladriere L, Ortis F, Grieco FA, et al. Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia. 2010;53(7):1395–405.

    Article  PubMed  CAS  Google Scholar 

  9. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 2: ketosis-prone atypical diabetes mellitus. Diabetes Metab. 2002;28(1):5–12.

    PubMed  CAS  Google Scholar 

  10. Sobngwi E, Gautier JF. Adult-onset idiopathic type I or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia. 2002;45(2):283–5.

    Article  PubMed  CAS  Google Scholar 

  11. Choukem SP, Sobngwi E, Fetita LS, Boudou P, De Kerviler E, Boirie Y, et al. Multitissue insulin resistance despite near-normoglycemic remission in Africans with ketosis-prone diabetes. Diabetes Care. 2008;31(12):2332–7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Choukem SP, Sobngwi E, Boudou P, Fetita LS, Porcher R, Ibrahim F, et al. Beta- and alpha-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission. Diabetes Care. 2013;36(1):118–23.

    Article  PubMed  CAS  Google Scholar 

  13. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004;53(3):645–53.

    Article  PubMed  CAS  Google Scholar 

  14. Concha LL, Durruty AP, Garcia de Los Rios AM. Ketosis prone type 2 diabetes (KPD). Rev Med Chil. 2015;143(9):1215–8.

    Article  Google Scholar 

  15. Ramos-Roman MA, Burgess SC, Browning JD. Metabolomics, stable isotopes, and A-beta+ ketosis-prone diabetes. Diabetes. 2013;62(3):682–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Balti EV, Ngo-Nemb MC, Lontchi-Yimagou E, Atogho-Tiedeu B, Effoe VS, Akwo EA, et al. Association of HLA class II markers with autoantibody-negative ketosis-prone atypical diabetes compared to type 2 diabetes in a population of sub-Saharan African patients. Diabetes Res Clin Pract. 2015;107(1):31–6.

    Article  PubMed  CAS  Google Scholar 

  17. Mauvais-Jarvis F, Boudou P, Sobngwi E, Riveline JP, Kevorkian JP, Villette JM, et al. The polymorphism Gly574Ser in the transcription factor HNF-1alpha is not a marker of adult-onset ketosis-prone atypical diabetes in afro-Caribbean patients. Diabetologia. 2003;46(5):728–9.

    Article  PubMed  CAS  Google Scholar 

  18. Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet. 2004;13(24):3151–9.

    Article  PubMed  CAS  Google Scholar 

  19. Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab. 2005;90(8):4446–51.

    Article  PubMed  CAS  Google Scholar 

  20. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, et al. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care. 1999;22(9):1517–23.

    Article  PubMed  CAS  Google Scholar 

  21. Sobngwi E, Choukem SP, Agbalika F, Blondeau B, Fetita LS, Lebbe C, et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA. 2008;299(23):2770–6.

    Article  PubMed  CAS  Google Scholar 

  22. Brooks-Worrell BM, Iyer D, Coraza I, Hampe CS, Nalini R, Ozer K, et al. Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes. Diabetes Care. 2013;36(12):4098–103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al. Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med. 2017;34(3):426–31.

    Article  PubMed  CAS  Google Scholar 

  24. Lontchi-Yimagou E, Nguewa JL, Assah F, Noubiap JJ, Boudou P, Djahmeni E, et al., Ketosis-prone atypical diabetes in Cameroonian people with hyperglycaemic crisis: frequency, clinical and metabolic phenotypes. Diabet Med 2016.

  25. Roy MS, Janal MN, Crosby J, Donnelly R. Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes. Invest Ophthalmol Vis Sci. 2013;54(8):5471–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Imai Y, Dobrian AD, Weaver JR, Butcher MJ, Cole BK, Galkina EV, et al. Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab. 2013;15(Suppl 3):117–29.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Butcher MJ, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia. 2014;57(3):491–501.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53(Suppl 1):S119–24.

    Article  PubMed  CAS  Google Scholar 

  30. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53(8):2079–86.

    Article  PubMed  CAS  Google Scholar 

  31. Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, et al. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus study. Immun Ageing. 2012;9(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We are grateful to all the participants of the study.

Funding

ELY received a fellowship grant from L’ INSTITUT SERVIER and from Service of Action and Cooperation of the French embassy in Cameroon.

Author information

Authors and Affiliations

  1. Laboratory for Molecular Medicine and Metabolism, Biotechnology Center, University of Yaoundé 1, PO Box 87, Yaoundé, Cameroon

    Eric Lontchi-Yimagou, Babara Atogho-Tiedeu, Jean Claude Mbanya & Eugène Sobngwi

  2. Unit of Hormonal Biology, Department of Biochemistry, Saint-Louis University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), 1 avenue Claude Vellefaux, 75010, Paris, France

    Philippe Boudou & Jean-Francois Gautier

  3. Inserm UMRS 1138, Cordeliers Research Centre, University Paris-6, 75006, Paris, France

    Jean Louis Nguewa & Jean-Francois Gautier

  4. Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa

    Jean Jacques Noubiap

  5. University hospital of Birmingham, Birmingham, UK

    Vicky Kamwa

  6. National Obesity Centre, Yaoundé Central Hospital, Yaoundé, Cameroon

    Eric Noel Djahmeni, Martine Etoa, Gaelle Lemdjo, Mesmin Yefou Dehayem, Jean Claude Mbanya & Eugène Sobngwi

  7. Department of Physiological Sciences and Biochemistry, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon

    Marcel Azabji-Kenfack

  8. Department of Internal Medicine, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon

    Jean Claude Mbanya & Eugène Sobngwi

Authors
  1. Eric Lontchi-Yimagou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Boudou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean Louis Nguewa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Jacques Noubiap
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vicky Kamwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eric Noel Djahmeni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Babara Atogho-Tiedeu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marcel Azabji-Kenfack
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Martine Etoa
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Gaelle Lemdjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Mesmin Yefou Dehayem
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jean Claude Mbanya
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jean-Francois Gautier
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Eugène Sobngwi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ELY, ES, JFG and JCM: study design and conception, data collection and analysis, and drafting of the manuscript. PB, JLN: data analysis and drafting of the manuscript. JJN, VK, END, BAT, MAK, MT, GL, MYD: data interpretation, editing and review of the manuscript. All authors read and approved of the final manuscript.

ELY, ES, JFG and JCM are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding author

Correspondence to Eric Lontchi-Yimagou.

Ethics declarations

Ethics approval and consent to participate

This study was performed in accordance with the guidelines of the Helsinki Declaration and was approved by the National Ethics Committee of Cameroon. All participants provided written informed consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lontchi-Yimagou, E., Boudou, P., Nguewa, J.L. et al. Acute phase ketosis-prone atypical diabetes is associated with a pro-inflammatory profile: a case-control study in a sub-Saharan African population. J Diabetes Metab Disord 17, 37–43 (2018). https://doi.org/10.1007/s40200-018-0336-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-018-0336-8

Keywords

search

Navigation